Social media is loaded with personal accounts of people shedding pounds while taking Ozempic, Wegovy and Mounjaro causing a controversial boom in the drug market. With the exception of Wegovy, these drugs have only been approved to treat Type 2 diabetes, but that hasn't stopped some from taking them for weight loss.
So how do they work, what are their side effects, and what unintended consequences are already arising as people rush to take them?
0:00 What are these new weight-loss drugs? 1:01 How drugs like Ozempic and Wegovy work in your body to help shed pounds 2:33 Why the market for weight-loss drugs is both growing and controversial 3:35 Side effects from the drugs
I’m Daniela Hernandez, a health and science reporter for WSJ, and on this channel I’ll be covering a variety of subjects from neuroscience to the science of food and public health. If you’re interested in science and health and how cutting edge research impacts our lives, don’t forget to subscribe.
Comments are disabled for this video.
People are raving about a new way to lose weight.
So I'm now calling it the skinny pen.
Ozempic was originally developed
to help patients manage diabetes.
Then people and drug companies saw a beneficial side effect.
It also helped with weight loss.
Obesity and diabetes are related.
Having obesity means you're more likely
to develop diabetes and then other chronic conditions
like heart disease.
So addressing weight was almost like a one-two punch
to treat two major public health problems.
Now there are more of these drugs available.
Let's go over how they work, their side effects,
and the unintended consequences of their new popularity.
The most popular, Ozempic, Wegovy, and Mungero,
are actually quite similar.
All of them come packaged in injection pens
with adjustable dosing.
The Novo Nordisk version actually has two names.
Ozempic, which is approved for type 2 diabetes,
and Wegovy, which is approved for weight loss.
Eli Lilly's, which is only approved
for type 2 diabetes right now, is called Mungero.
But it's likely a version of it will soon be approved
for weight loss too.
Their active ingredients mimic the effects
of a naturally occurring hormone called GLP-1.
Hormones are chemical messengers
that relay information about the body
from one organ to another.
Here's an example.
Anytime you eat, especially if it's sugars or fats,
cells in the small and large intestines release GLP-1.
It gets pumped through the blood
to different parts of the body.
When it interacts with the pancreas,
it promotes the production and release of insulin.
Insulin helps regulate blood sugar levels,
which is important for people with diabetes.
Plus, as my coworker, Peter Loftus,
who's been covering GLP-1 drugs, told me,
Some research suggests that it does that
by interacting with various brain areas,
including the hypothalamus,
which is the brain's control coordinating center.
The brain reaches that directly interact with GLP-1
It also helps slow down the emptying of the stomach.
So that's the part that becomes useful in weight loss.
And the effects of these drugs
on weight loss can be dramatic.
People taking Rigovi generally lose
between 15 and 18% of body weight.
And with Munjaro, patients have lost even more than that,
up to nearly 23%.
That may be because Munjaro contains
a second hormone called GIP,
which also stimulates insulin secretion.
These effects are one reason why prescriptions are soaring.
For Ozempic, they're up 102% in the last year.
The other factor behind the market boom is social media.
And that's where things start getting complicated
and even controversial.
And that's adding to the demand
that really has complicated the whole supply balance.
Because the drugs are approved,
doctors can legally prescribe them at their own discretion.
A journal analysis found that telehealth companies
were flooding social media with ads
and were prescribing these drugs with little oversight,
sometimes to people who don't meet the criteria
for taking these meds.
The same journal report found that ads claim
that no diet or exercise is needed for it to work.
And that's not necessarily true.
If you stop, chances are you'll put the pounds back on again.
Plus, the drugs are just too new
to know what the long-term effects are,
especially for people taking them for casual weight loss.
They've only been tested in people
who are overweight or have obesity.
But as with any medication, there are known side effects.
For these drugs, that includes nausea, diarrhea, and vomiting.
Some of these gastrointestinal issues were so bad
that people in clinical trials
opted to stop taking the drugs.
More of these drugs will soon be approved for weight loss,
but that doesn't mean they'll be easy to access.
They can cost anywhere from $800 to more than $1,300 a month.
Insurance typically covers them for diabetes,
but not for weight loss.
Pete told me that has to do
with the enduring stigma around obesity.
And that has spilled into how people are medically treated.
And it's something doctors are trying to change.